Adapalene/benzoyl peroxide - Sol-Gel

Drug Profile

Adapalene/benzoyl peroxide - Sol-Gel

Alternative Names: ADUO; Benzoyl-peroxide/adapalene - Sol-Gel

Latest Information Update: 17 Feb 2016

Price : $50

At a glance

  • Originator Sol-Gel Technologies
  • Class Anti-infectives; Anti-inflammatories; Antiacnes; Benzoic acids; Keratolytics; Naphthalenes; Oxidants; Retinoids; Small molecules
  • Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Acne vulgaris

Most Recent Events

  • 16 Feb 2016 Preclinical trials in Acne vulgaris in Israel (Topical) prior to February 2016 (Sol-Gel Technologies pipeline, February 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top